Übersichtsarbeit


Mythen zu Injizierbaren Füllmaterialien

Myths on injectable fillers

Keywords | Summary | Correspondence | Literature

Keywords

, , , ,

Schlüsselworte

, , ,

Summary

Myths in the field of injectables might ease, aggravate or be of no meaning at all for the use of injectable fillers. The goal of the following review is to give an mostly evidence based view on this field to help specifically new users in that field.

Zusammenfassung

Mythen können die Anwendung von injizierbaren Füllmaterialien erleichtern, erschweren oder letztendlich von keinerlei Bedeutung sein. In der folgenden Übersicht werden einige Mythen aus dem Blickwinkel der evidenzbasierten Medizin skizziert in der Hoffnung damit gerade neuen Anwendern den Umgang mit diesen Materialien zu erleichtern.

Leider haben Sie sich nicht eingeloggt, um den Beitrag lesen zu können. Bitte loggen Sie sich ein oder beantragen Sie Ihre Zugangsberechtigung. Vielen Dank. Weitere Informationen finden Sie hier>

Korrespondenz-Adresse

Prof. Dr. med. Berthold Rzany ScM
RZANY & HUND
Privatpraxis für Dermatologie und Ästhetische Medizin
Prof. Dr. med. Berthold Rzany ScM und Frau Dr. med. Martina Hund
Kurfürstendamm 183
D-10707 Berlin
rzany@kudamm183.de
www.kudamm183.de

Conflict of Interests

Berthold Rzany ist Referent und Berater der Galderma Laboratorium GmbH, der Merz Pharmaceuticals GmbH und der Sinclair Pharma GmbH.

Literatur

1. Schuller-Petrovic S, Pavlovic MD, Schuller SS et al. (2013) Early granulomatous foreign body reactions to a novel alginate dermal filler: the system’s failure? JEADV 27: 121-123.
2. Ascher B, Bayerl C, Brun P, Kestemont P, Rzany B, Poncet M, Guennoun M, Podda M (2011) Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of severe nasolabial lines – 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Dermatol. 10(2):94-8.
3. Rzany B, Bayerl C, Bodokh I, Boineau D, Dirschka T, Queille-Roussel C, Sebastian M, Sommer B, Poncet M, Guennoun M, Podda M. Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Laser Ther. 2011.
4. Andre P (2004) Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA -- Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001. Journal of the European Academy of Dermatology and Venereology : JEADV 18:422-425
5. Narins RS, Baumann L, Brandt FS, Fagien S, Glazer S, Lowe NJ, Monheit GD, Rendon MI, Rohrich RJ, Werschler WP (2010) A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol. 62(3):448-62.
6. Kølle SF, Fischer-Nielsen A, Mathiasen AB, Elberg JJ, Oliveri RS, Glovinski PV, Kastrup J, Kirchhoff M, Rasmussen BS, Talman ML, Thomsen C, Dickmeiss E, Drzewiecki KT (2013) Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial. Lancet 382(9898):1113-20.
7. Redaelli A, Romano D, Marcianó A (2010) Face and neck revitalization with platelet-rich plasma (PRP): clinical outcome in a series of 23 consecutively treated patients. J Drugs Dermatol. 9(5):466-72.
8. Bachmann F, Erdmann R, Hartmann V et al. (2011) Adverse reactions caused by consecutive injections of different fillers in the same facial region: risk assessment based on the results from the Injectable Filler Safety study. Journal of the European Academy of Dermatology and Venereology: JEADV 25:902-912.
9. Kim DW, Yoon ES, Ji YH et al. (2011) Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management. Journal of plastic, reconstructive & aesthetic surgery : JPRAS 64:1590-1595.
10. Lazzeri D, Agostini T, Figus M et al. (2012) Blindness following cosmetic injections of the face. Plast Reconstr Surg. 129(4):995-1012.
11. Rzany B, Bachmann F, Nast A (2013) Komplikationen auf injizierbare Füllmaterialien: Diagnose und Therapie. Hautarzt. 64(3):163-70.
12. Dadzie OE, Mahalingam M, Parada M et al. (2008) Adverse cutaneous reactions to soft tissue fillers--a review of the histological features. Journal of cutaneous pathology 35: 536-548.
13. Rzany B, Becker-Wegerich P, Bachmann F et al. (2009) Hyaluronidase in the correction of hyaluronic acid-based fillers: a review and a recommendation for use. J Cosmet Dermatol. 8:317-323.
14. Bjarnsholt T, Tolker-Nielsen T, Givskov M et al. (2009) Detection of bacteria by fluorescence in situ hybridization in culture-negative soft tissue filler lesions. Dermatol Surg. 35 Suppl 2: 1620-1624.
15. Wiest LG, Stolz W, Schroeder JA (2009) Electron microscopic documentation of late changes in permanent fillers and clinical management of granulomas in affected patients. Dermatol Surg. 35 Suppl 2: 1681-1688.
16. Hanke CW, Rohrich RJ, Busso M et al. (2011) Facial Soft-Tissue Fillers conference: Assessing the State of the Science. JAAD. 64: S66-85, S85 e61-136.

Ausgabe